After medical device M&A picked up last year, 2026 is off to a busy start. Boston Scientific’s planned $14.5 billion acquisition of Penumbra, a company that makes thrombectomy and embolization devices, was the largest purchase so far this year. In another multibillion-dollar deal, Danaher announced plans this month to buy patient monitoring firm Masimo. Several medtech firms have also announced major divestitures in the past year. Here are the top M&A deals so far this year.
Read the full article: Medtech M&A Starts Off Strong in 2026 //
Source: https://www.medtechdive.com/news/medtech-ma-starts-off-strong-in-2026/813228/